newsfilter
← Latest News
Business Wire·

Emmaus Life Sciences Reports Annual Financial Results

Emmaus Life Sciences, Inc. (OTCQB:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its financial condition and results of operations as of and for